Dr Pal’s research centres around applying CRISPR-based technologies for genome editing and diagnostics. During his research career, Dr Pal applied gene targeting approaches to mimic and study human diseases, such as metabolic disorders and cancer. Dr Pal’s research interests also include developing novel diagnostic tools using CRISPR technology. He is a co-investigator in our periodontitis program and in this context is also co-supervising a PhD project aimed at developing a CRISPR-based diagnostic assay.